CPA BCom - Medicure Chief Officer
| MCUJF Stock | USD 0.70 0.00 0.00% |
Insider
CPA BCom is Chief Officer of Medicure
| Phone | 204 487 7412 |
| Web | https://www.medicure.com |
Medicure Management Efficiency
The company has return on total asset (ROA) of 0.021 % which means that it generated a profit of $0.021 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1483 %, meaning that it generated $0.1483 on every $100 dollars invested by stockholders. Medicure's management efficiency ratios could be used to measure how well Medicure manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jonathan Ross | Vext Science | N/A | |
| Mark Doolittle | Covalon Technologies | N/A | |
| Geri Plotzke | Pacific Health Care | 80 | |
| Jason Nguyen | Vext Science | N/A | |
| Kathy Torres | Pacific Health Care | 73 | |
| Donald Balzano | Pacific Health Care | 77 | |
| Ron Hebert | Covalon Technologies | N/A | |
| Greg Leszczynski | Covalon Technologies | N/A | |
| Miriam MBA | Pharma Bio Serv | N/A | |
| Hamed Abbasian | Covalon Technologies | N/A | |
| Jason Gorel | Covalon Technologies | N/A | |
| Stephan Bankosz | Vext Science | N/A | |
| Simon Smith | Covalon Technologies | N/A | |
| Eric Offenberger | Vext Science | N/A | |
| Elaine Zhang | Covalon Technologies | N/A | |
| Gerry Arambula | Covalon Technologies | N/A | |
| David Kim | Pacific Health Care | 50 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.021 |
Medicure Leadership Team
Elected by the shareholders, the Medicure's board of directors comprises two types of representatives: Medicure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medicure. The board's role is to monitor Medicure's management team and ensure that shareholders' interests are well served. Medicure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medicure's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neil Owens, President COO | ||
| CPA BCom, Chief Officer | ||
| Albert Friesen, Founder, Chairman and CEO | ||
| Jamie Gowryluk, VP Operations | ||
| Reuben Saba, VP Affairs |
Medicure Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Medicure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.021 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 5.67 M | |||
| Shares Outstanding | 10.25 M | |||
| Shares Owned By Insiders | 26.70 % | |||
| Shares Owned By Institutions | 23.51 % | |||
| Number Of Shares Shorted | 15.08 K | |||
| Price To Earning | 11.45 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.